Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

被引:50
|
作者
Wieduwilt, Matthew J. [1 ]
Metheny, Leland [2 ]
Zhang, Mei-Jie [3 ,4 ]
Wang, Hai-Lin [3 ]
Estrada-Merly, Noel [3 ]
Marks, David, I [5 ]
Al-Homsi, A. Samer [6 ]
Muffly, Lori [7 ]
Chao, Nelson [8 ]
Rizzieri, David [9 ]
Gale, Robert Peter [10 ]
Gadalla, Shahinaz M. [11 ]
Cairo, Mitchell [12 ]
Mussetti, Alberto [13 ,14 ]
Gore, Steven [15 ]
Bhatt, Vijaya Raj [16 ]
Patel, Sagar S. [17 ]
Michelis, Fotios, V [18 ]
Inamoto, Yoshihiro [19 ]
Badawy, Sherif M. [20 ,21 ]
Copelan, Edward [22 ]
Palmisiano, Neil [23 ]
Kharfan-Dabaja, Mohamed A. [24 ]
Lazarus, Hillard M. [25 ]
Ganguly, Siddhartha [26 ]
Bredeson, Christopher [27 ]
Diaz Perez, Miguel Angel [28 ]
Cassaday, Ryan [29 ]
Savani, Bipin N. [30 ]
Ballen, Karen [31 ]
Martino, Rodrigo [32 ]
Wirk, Baldeep [33 ]
Bacher, Ulrike [34 ]
Aljurf, Mahmoud [35 ]
Bashey, Asad [36 ]
Murthy, Hemant S. [24 ]
Yared, Jean A. [37 ]
Aldoss, Ibrahim [38 ]
Farhadfar, Nosha [39 ]
Liu, Hongtao [40 ]
Abdel-Azim, Hisham [41 ]
Waller, Edmund K. [42 ]
Solh, Melhem [43 ]
Seftel, Matthew D. [44 ]
van der Poel, Marjolein [45 ]
Grunwald, Michael R. [22 ]
Liesveld, Jane L. [46 ]
Kamble, Rammurti T. [47 ]
McGuirk, Joseph [26 ]
Munker, Reinhold [48 ]
机构
[1] Univ Oklahoma, Stephenson Canc Ctr, Oklahoma City, OK 73106 USA
[2] Univ Hosp Seidman Canc Ctr, Cleveland, OH USA
[3] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA
[4] Med Coll Wisconsin, Inst Hlth & Equ, Div Biostat, Milwaukee, WI 53226 USA
[5] Univ Hosp Bristol Natl Hlth Serv Trust, Adult Bone Marrow Transplant, Bristol, Avon, England
[6] New York Univ Langone Hlth, New York, NY USA
[7] Stanford Univ, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA
[8] Duke Univ, Med Ctr, Dept Med, Div Cell Therapy & Hematol, Durham, NC 27710 USA
[9] Duke Univ, Div Hematol Malignancies & Cellular Therapy, Durham, NC USA
[10] Imperial Coll London, Haematol Res Ctr, Dept Immunol & Inflammat, London, England
[11] NCI, Div Canc Epidemiol & Genet, Clin Genet Branch, NIH, Rockville, MD USA
[12] New York Med Coll, Dept Pediat, Div Pediat Hematol Oncol & Stem Cell Transplantat, Valhalla, NY 10595 USA
[13] Inst Catala Oncol Hosp, Hematol Dept, Barcelona, Spain
[14] Inst Catala Oncol, Inst Invest Biomed Bellvitge, Lhospitalet De Llobregat, El Prat De Llob, Spain
[15] Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA
[16] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE USA
[17] Univ Utah, Huntsman Canc Inst, Blood & Marrow Transplant Program, Salt Lake City, UT USA
[18] Princess Margaret Canc Ctr, Allogene Blood & Marrow Transplant Program, Toronto, ON, Canada
[19] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo, Japan
[20] Ann & Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol & Stem Cell Transplant, Chicago, IL 60611 USA
[21] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA
[22] Atrium Hlth, Dept Hematol Oncol & Blood Disorders, Levine Canc Inst, Charlotte, NC USA
[23] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[24] Mayo Clin, Blood & Marrow Transplantat Program, Div Hematol Oncol, Jacksonville, FL 32224 USA
[25] Case Western Reserve Univ, Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA
[26] Univ Kansas Hlth Syst, Div Hematol Malignancies & Cellular Therapeut, Kansas City, KS USA
[27] Ottawa Hosp, Transplant & Cellular Therapy Program, Ottawa, ON, Canada
[28] Hosp Infantil Univ Nino Jesus, Dept Hematol Oncol, Madrid, Spain
[29] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA
[30] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA
[31] Univ Virginia Hlth Syst, Div Hematol Oncol, Charlottesville, VA USA
[32] Hosp Santa Creu & Sant Pau, Div Clin Hematol, Barcelona, Spain
[33] Penn State Canc Inst, Bone Marrow Transplant Program, Hershey, PA USA
[34] Univ Bern, Bern Univ Hosp, Dept Hematol, Inselspital, Bern, Switzerland
[35] King Faisal Specialist Hosp Ctr & Res, Dept Oncol, Riyadh, Saudi Arabia
[36] Northside Hosp, Blood & Marrow Transplant Program, Atlanta, GA USA
[37] Univ Maryland, Dept Med, Greenebaum Comprehens Canc Ctr, Blood & Marrow Transplantat Program,Div Hematol O, Baltimore, MD 21201 USA
[38] City Hope Med Ctr, Duarte, CA USA
[39] Univ Florida, Div Hematol Oncol, Coll Med, Gainesville, FL USA
[40] Univ Chicago Med, Sect Hematol Oncol, Chicago, IL USA
[41] Univ Southern Calif, Childrens Hosp Los Angeles, Div Hematol Oncol & Blood & Marrow Transplantat, Keck Sch Med, Los Angeles, CA 90007 USA
[42] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[43] Northside Hosp, Blood & Marrow Transplant Grp Georgia, Atlanta, GA USA
[44] Univ British Columbia, Dept Med, Vancouver, BC, Canada
[45] Maastricht Univ, Med Ctr, Maastricht, Netherlands
[46] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA
[47] Baylor Coll Med, Ctr Cell & Gene Therapy, Div Hematol & Oncol, Houston, TX 77030 USA
[48] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA
[49] Univ Grenoble Alpes, Ctr Hosp Univ Grenoble Alpes, Dept Hematol, Grenoble, France
[50] Catholic Univ Korea, Div Hematol, Seoul St Marys Hosp, Seoul, South Korea
关键词
MINIMAL RESIDUAL DISEASE; VERSUS-HOST-DISEASE; POSTTRANSPLANTATION CYCLOPHOSPHAMIDE; DONOR TRANSPLANTATION; GVHD PROPHYLAXIS; ADULT PATIENTS; RELAPSE; IMPACT; REMISSION; SURVIVAL;
D O I
10.1182/bloodadvances.2021004916
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of haploidentical hematopoietic cell transplantation (HCT) using posttransplant cyclophosphamide (PTCy) for acute lymphoblastic leukemia (ALL) is being defined. We performed a retrospective, multivariable analysis comparing outcomes of HCT approaches by donor for adults with ALL in remission. The primary objective was to compare overall survival (OS) among haploidentical HCTs using PTCy and HLA-matched sibling donor (MSD), 8/8 HLAmatched unrelated donor (MUD), 7 /8 HLA-MUD, or umbilical cord blood (UCB) HCT. Comparing haploidentical HCT to MSD HCT, we found that OS, leukemia-free survival (LFS), nonrelapse mortality (NRM), relapse, and acute graft-versus-host disease (aGVHD) were not different but chronic GVHD (cGVHD) was higher in MSD HCT. Compared with MUD HCT, OS, LFS, and relapse were not different, but MUD HCT had increased NRM (hazard ratio [HR], 1.42; P = .02), grade 3 to 4 aGVHD (HR, 1.59; P = .005), and cGVHD. Compared with 7/8 UD HCT, LFS and relapse were not different, but 7/8 UD HCT had worse OS (HR, 1.38; P = .01) and increased NRM (HR, 2.13; P <_ .001), grade 3 to 4 aGVHD (HR, 1.86; P = .003), and cGVHD (HR, 1.72; P <_ .001). Compared with UCB HCT, late OS, late LFS, relapse, and cGVHD were not different but UCB HCT had worse early OS (<_18 months; HR, 1.93; P < .001), worse early LFS (HR, 1.40; P = .007) and increased incidences of NRM (HR, 2.08; P < .001) and grade 3 to 4 aGVHD (HR, 1.97; P < .001). Haploidentical HCT using PTCy showed no difference in survival but less GVHD compared with traditional MSD and MUD HCT and is the preferred alternative donor HCT option for adults with ALL in complete remission.
引用
收藏
页码:339 / 357
页数:19
相关论文
共 50 条
  • [41] Haploidentical hematopoietic cell transplantation with or without an unrelated cord blood unit for adult acute myeloid leukemia: a multicenter, randomized, open-label, phase 3 trial
    Zhou, Biqi
    Chen, Jia
    Liu, Tianhui
    Ye, Yishan
    Zhang, Yanming
    Ding, Yiyang
    Liu, Hong
    Zhu, Mingqing
    Ma, Xiao
    Li, Xiaoli
    Zhao, Longfei
    Lin, Zhihong
    Huang, He
    Xu, Yang
    Wu, Depei
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [42] Is unrelated donor or haploidentical hematopoietic transplantation preferred for patients with acute myeloid leukemia in remission?
    Champlin, Richard
    HAEMATOLOGICA, 2020, 105 (02) : 252 - 254
  • [43] Haploidentical transplantation for acute lymphoblastic leukemia in childhood
    Klingebiel, T
    Handgretinger, R
    Lang, P
    Bader, P
    Niethammer, D
    BLOOD REVIEWS, 2004, 18 (03) : 181 - 192
  • [44] Unrelated cord blood transplantation for childhood acute myeloid leukemia
    Michel, G
    Rocha, V
    Arcese, W
    Chan, K
    Filipovich, A
    Vowels, M
    Ortega, J
    Bordigoni, P
    Shaw, P
    Yaniv, I
    Ionescu, I
    Garnier, F
    Gluckman, E
    BONE MARROW TRANSPLANTATION, 2003, 31 : S47 - S48
  • [45] Transient chromosomal rearrangements in three children with acute lymphoblastic leukemia after unrelated cord blood transplantation
    Otero, L.
    de Souza Fernandez, T.
    Padilha, T. F.
    Carestiato, F. N.
    Bouzas, L. F.
    Abdelhay, E.
    BONE MARROW TRANSPLANTATION, 2011, 46 (03) : 452 - 454
  • [46] Transient chromosomal rearrangements in three children with acute lymphoblastic leukemia after unrelated cord blood transplantation
    L Otero
    T de Souza Fernandez
    T F Padilha
    F N Carestiato
    L F Bouzas
    E Abdelhay
    Bone Marrow Transplantation, 2011, 46 : 452 - 454
  • [47] Favorable Outcome of Unrelated Cord Blood Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Onishi, Yasushi
    Sasaki, Osamu
    Ichikawa, Satoshi
    Inokura, Kyoko
    Katsuoka, Yuna
    Ohba, Rie Ohtsuka
    Okitsu, Yoko
    Kohata, Katsura
    Ohguchi, Hiroto
    Fukuhara, Noriko
    Yokoyama, Hisayuki
    Yamada, Minami Fujiwara
    Yamamoto, Joji
    Ishizawa, Kenichi
    Kameoka, Junichi
    Harigae, Hideo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (07) : 1093 - 1097
  • [48] Unrelated cord blood transplantation with myeloablative conditioning for pediatric acute lymphoblastic leukemia in remission: prognostic factors
    Yuta Kawahara
    Akira Morimoto
    Jiro Inagaki
    Katsuyoshi Koh
    Maiko Noguchi
    Hiroaki Goto
    Nao Yoshida
    Yuko Cho
    Tsukasa Hori
    Mitsuteru Hiwatari
    Keisuke Kato
    Atsushi Ogawa
    Yoshiko Hashii
    Masami Inoue
    Koji Kato
    Yoshiko Atsuta
    Fumihiko Kimura
    Motohiro Kato
    Bone Marrow Transplantation, 2021, 56 : 357 - 367
  • [49] UNRELATED CORD BLOOD TRANSPLANTATION FOR CENTRAL NERVOUS SYSTEM RELAPSE IN HIGH RISK ACUTE LYMPHOBLASTIC LEUKEMIA
    Zheng, C.
    Tang, B.
    Tong, J.
    Liu, H.
    Sun, Z.
    HAEMATOLOGICA, 2013, 98 : 153 - 153
  • [50] HLA-mismatched unrelated umbilical cord blood transplantation in a child with acute lymphoblastic leukemia.
    Sun, ZM
    Wang, ZY
    Zhu, WB
    BLOOD, 2000, 96 (11) : 365B - 365B